BACKGROUND: The discoidin domain receptor 1 (DDR1) is activated by collagens, upregulated in injured and fibrotic kidneys, and contributes to fibrosis by regulating extracellular matrix production, but how DDR1 controls fibrosis is poorly understood. DDR1 is a receptor tyrosine kinase (RTK). RTKs can translocate to the nucleus via a nuclear localization sequence (NLS) present on the receptor itself or a ligand it is bound to. In the nucleus, RTKs regulate gene expression by binding chromatin directly or by interacting with transcription factors. METHODS: To determine whether DDR1 translocates to the nucleus and whether this event is mediated by collagen-induced DDR1 activation, we generated renal cells expressing wild-type or mutant forms of DDR1 no longer able to bind collagen. Then, we determined the location of the DDR1 upon collagen stimulation. Using both biochemical assays and immunofluorescence, we analyzed the steps involved in DDR1 nuclear translocation. RESULTS: We show that although DDR1 and its natural ligand, collagen, lack an NLS, DDR1 is present in the nucleus of injured human and mouse kidney proximal tubules. We show that DDR1 nuclear translocation requires collagen-mediated receptor activation and interaction of DDR1 with SEC61B, a component of the Sec61 translocon, and nonmuscle myosin IIA and β-actin. Once in the nucleus, DDR1 binds to chromatin to increase the transcription of collagen IV, a major collagen upregulated in fibrosis. CONCLUSIONS: These findings reveal a novel mechanism whereby activated DDR1 translates to the nucleus to regulate synthesis of profibrotic molecules.
BACKGROUND: The discoidin domain receptor 1 (DDR1) is activated by collagens, upregulated in injured and fibrotic kidneys, and contributes to fibrosis by regulating extracellular matrix production, but how DDR1 controls fibrosis is poorly understood. DDR1 is a receptor tyrosine kinase (RTK). RTKs can translocate to the nucleus via a nuclear localization sequence (NLS) present on the receptor itself or a ligand it is bound to. In the nucleus, RTKs regulate gene expression by binding chromatin directly or by interacting with transcription factors. METHODS: To determine whether DDR1 translocates to the nucleus and whether this event is mediated by collagen-induced DDR1 activation, we generated renal cells expressing wild-type or mutant forms of DDR1 no longer able to bind collagen. Then, we determined the location of the DDR1 upon collagen stimulation. Using both biochemical assays and immunofluorescence, we analyzed the steps involved in DDR1 nuclear translocation. RESULTS: We show that although DDR1 and its natural ligand, collagen, lack an NLS, DDR1 is present in the nucleus of injured human and mouse kidney proximal tubules. We show that DDR1 nuclear translocation requires collagen-mediated receptor activation and interaction of DDR1 with SEC61B, a component of the Sec61 translocon, and nonmuscle myosin IIA and β-actin. Once in the nucleus, DDR1 binds to chromatin to increase the transcription of collagen IV, a major collagen upregulated in fibrosis. CONCLUSIONS: These findings reveal a novel mechanism whereby activated DDR1 translates to the nucleus to regulate synthesis of profibrotic molecules.
Authors: Michal K Stachowiak; Xiaohong Fang; Jason M Myers; Star M Dunham; Ronald Berezney; Pamela A Maher; Ewa K Stachowiak Journal: J Cell Biochem Date: 2003-11-01 Impact factor: 4.429
Authors: Soyeon Ko; Kyung Hee Jung; Young-Chan Yoon; Beom Seok Han; Min Seok Park; Yun Ji Lee; Sang Eun Kim; Ye Jin Cho; Pureunchowon Lee; Joo Han Lim; Ji-Kan Ryu; Kewon Kim; Tae Young Kim; Sungwoo Hong; So Ha Lee; Soon-Sun Hong Journal: Am J Cancer Res Date: 2022-09-15 Impact factor: 5.942
Authors: Marco Prunotto; Rafael Fridman; R Daniel Bonfil; Wei Chen; Semir Vranic; Anjum Sohail; Dongping Shi; Hyejeong Jang; Hyeong-Reh Kim Journal: Cancer Cell Int Date: 2021-09-21 Impact factor: 6.429
Authors: Eno Hysi; Xiaolin He; Muhannad N Fadhel; Tianzhou Zhang; Adriana Krizova; Michael Ordon; Monica Farcas; Kenneth T Pace; Victoria Mintsopoulos; Warren L Lee; Michael C Kolios; Darren A Yuen Journal: JCI Insight Date: 2020-05-21
Authors: Julie S Di Martino; Ana Rita Nobre; Chandrani Mondal; Isra Taha; Eduardo F Farias; Elana J Fertig; Alexandra Naba; Julio A Aguirre-Ghiso; Jose Javier Bravo-Cordero Journal: Nat Cancer Date: 2021-12-13
Authors: Corina M Borza; Gema Bolas; Xiuqi Zhang; Mary Beth Browning Monroe; Ming-Zhi Zhang; Jens Meiler; Marcin J Skwark; Raymond C Harris; Lynne A Lapierre; James R Goldenring; Magnus Hook; Jose Rivera; Kyle L Brown; Birgit Leitinger; Matthew J Tyska; Markus Moser; Ralph T Böttcher; Roy Zent; Ambra Pozzi Journal: Front Cell Dev Biol Date: 2022-03-03
Authors: Manuel Chiusa; Wen Hu; Jozef Zienkiewicz; Xiwu Chen; Ming-Zhi Zhang; Raymond C Harris; Roberto M Vanacore; Jennifer A Bentz; Giuseppe Remuzzi; Ariela Benigni; Agnes B Fogo; Wentian Luo; Stavroula Mili; Matthew H Wilson; Roy Zent; Jacek Hawiger; Ambra Pozzi Journal: J Cell Biol Date: 2020-09-07 Impact factor: 10.539
Authors: Corina M Borza; Gema Bolas; Fabian Bock; Xiuqi Zhang; Favour C Akabogu; Ming-Zhi Zhang; Mark de Caestecker; Min Yang; Haichun Yang; Ethan Lee; Leslie Gewin; Agnes B Fogo; W Hayes McDonald; Roy Zent; Ambra Pozzi Journal: JCI Insight Date: 2022-02-08